HIGHLY CONFIDENTIAL & TRADE SECRET BREA EUROPE VI (CAYMAN) L.P. AMENDED AND RESTATED AGREEMENT OF EXEMPTED LIMITED PARTNERSHIP DATED FEBRUARY 26, 2020 EFFECTIVE MAY 8, 2019Highly Confidential • February 28th, 2020 • Blackstone Group Inc • Investment advice
AMENDED AND RESTATED AGREEMENT OF EXEMPTED LIMITED PARTNERSHIP, dated February 26, 2020, and effective May 8, 2019, of BREA Europe VI (Cayman) L.P., a Cayman Islands exempted limited partnership (the “Partnership”), by and between Blackstone Real Estate Associates Europe (Delaware) VI L.L.C., a Delaware limited liability company, as general partner of the Partnership (the “General Partner”), Mapcal Limited, as initial limited partner (the “Initial Limited Partner”), the limited partners listed as Limited Partners in the books and records of the Partnership, and such other persons that are admitted to the Partnership as partners after the date hereof in accordance herewith.
Akoustis Technologies, Inc.Highly Confidential • February 14th, 2017 • Akoustis Technologies, Inc. • Telephone & telegraph apparatus • New York
HIGHLY CONFIDENTIAL & TRADE SECRET BREA EUROPE VII (CAYMAN) L.P. AMENDED AND RESTATED AGREEMENT OF EXEMPTED LIMITED PARTNERSHIP DATED MAY 3, 2024 EFFECTIVE JUNE 30, 2023Highly Confidential • May 3rd, 2024 • Blackstone Inc. • Investment advice
AMENDED AND RESTATED AGREEMENT OF EXEMPTED LIMITED PARTNERSHIP, dated May 3, 2024, and effective June 30, 2023, of BREA Europe VII (Cayman) L.P., a Cayman Islands exempted limited partnership (the “Partnership”), by and between Blackstone Real Estate Associates Europe (Delaware) VII L.L.C., a Delaware limited liability company, as general partner of the Partnership (the “General Partner”), Mapcal Limited, as initial limited partner (the “Initial Limited Partner”), the limited partners listed as Limited Partners in the books and records of the Partnership, and such other persons that are admitted to the Partnership as partners after the date hereof in accordance herewith.
Waltham, Massachusetts 02451 RE: Advisory Agreement Dear Michelle:Highly Confidential • August 3rd, 2017 • OvaScience, Inc. • Pharmaceutical preparations
You and OvaScience, Inc. (the “Company”) are parties to that certain agreement governing your employment with the Company dated January 5, 2016 (the “Original Agreement”). We have agreed on a transition plan pursuant to which you will continue for a limited period of time as the Company’s Executive Chair and then transition into a non-employee, advisory role. This letter (this “Agreement”) shall be treated as an amendment to the Original Agreement. This Agreement is effective as of June 21, 2017 (the “Effective Date”).
